Vaccine-related Poliovirus Shedding in Trivalent Polio Vaccine and Human Immunodeficiency Virus Status: Analysis from Under Five Children

Overview

Journal BMC Res Notes

Publisher Biomed Central

Specialties Biology
General Medicine

Date 2017 Nov 5

PMID 29100529

Authors

Joanne Hassan

Laura Wangai

Peter Borus

Christopher Khayeka-Wandabwa

Lucy Wanja Karani

Mercy Kithinji

Michael Kiptoo

Affiliations

Soon will be listed here.

Abstract

Background: Poliomyelitis is an acute viral infection caused by poliovirus and transmitted via the fecal-oral route. The causative agent is one of the three serotypes of poliovirus (serotypes 1, 2, 3) that differ slightly in capsid protein. Prolonged vaccine-related poliovirus shedding in human immunodeficiency virus (HIV) positive individuals has been linked to possible reservoir for reintroduction of polioviruses after eradication. The study therefore aimed at estimating the duration for vaccine-related poliovirus shedding among potentially and HIV-infected persons.

Methods: Poliovirus excretion was studied following vaccination of children aged ≤ 59 month per human immunodeficiency virus status after national immunization days. Their medical records were reviewed to identify the child's HIV status, demographic and immunization data. Sequential stool samples were collected at site 2nd, 4th and 8th week after trivalent oral poliovirus vaccine (tOPV) was administered. To isolate suspected polioviruses and non-polio enteroviruses, characterize poliovirus subtypes by intratypic differentiation and Sabin vaccine derived poliovirus, real time polymerase chain reaction was applied. Shedding for ≥ 24 weeks was defined as long-term persistence.

Results: The mean age of the study population was 28.6 months, while the median age was 24 months. Of the children recruited, majority were in the 25-48 months (n = 12; 46.2%) age category. All the HIV-positive children (n = 10) had mild symptomatic HIV status and did shed vaccine-related polioviruses between weeks 2 and 4 respectively. No participant shed polioviruses for ≥ 6 weeks.

Conclusions: It was evident mildly symptomatic HIV+ children sustain the capacity to clear vaccine-related poliovirus. The oral poliovirus vaccine-2 (Sabin like) that was detected in one HIV-infected child's stool 6 weeks after the national immunization days was predominantly non revertant. There was no evident prolonged poliovirus shedding among the participants enlisted in the present study. High powered studies are desired to further corroborate these findings.

References

Espanol T, Garcia X, Caragol I, Sauleda S, Muntane C . Immunological abnormalities in pediatric AIDS. Immunol Invest. 1991; 20(2):215-21. DOI: 10.3109/08820139109050790. View

Troy S, Musingwini G, Halpern M, Huang C, Stranix-Chibanda L, Kouiavskaia D . Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants. J Infect Dis. 2013; 208(4):672-8. PMC: 3719901. DOI: 10.1093/infdis/jit208. View

Manirakiza A, Picard E, Ngbale R, Menard D, Gouandjika-Vasilache I . OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic. BMC Res Notes. 2010; 3:136. PMC: 2880960. DOI: 10.1186/1756-0500-3-136. View

HAMMON W, CORIELL L, Ludwig E, McAllister R, GREENE A, SATHER G . Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory-confirmed cases. J Am Med Assoc. 1954; 156(1):21-7. DOI: 10.1001/jama.1954.02950010023009. View

Dunn G, Klapsa D, Wilton T, Stone L, Minor P, Martin J . Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLoS Pathog. 2015; 11(8):e1005114. PMC: 4552295. DOI: 10.1371/journal.ppat.1005114. View

Hel Z, Xu J, Denning W, Helton E, Huijbregts R, Heath S . Dysregulation of Systemic and Mucosal Humoral Responses to Microbial and Food Antigens as a Factor Contributing to Microbial Translocation and Chronic Inflammation in HIV-1 Infection. PLoS Pathog. 2017; 13(1):e1006087. PMC: 5268400. DOI: 10.1371/journal.ppat.1006087. View

Pavlov D, van Zyl W, Kruger M, Blignaut L, Grabow W, Ehlers M . Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. Diagn Microbiol Infect Dis. 2005; 54(1):23-30. DOI: 10.1016/j.diagmicrobio.2005.08.011. View

. Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993. MMWR Morb Mortal Wkly Rep. 2001; 50(3):41-2, 51. View

Ryder R, Oxtoby M, Mvula M, Batter V, Baende E, Nsa W . Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr. 1993; 122(5 Pt 1):697-702. DOI: 10.1016/s0022-3476(06)80007-7. View

10.

Wood D, Sutter R, Dowdle W . Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ. 2000; 78(3):347-57. PMC: 2560716. View

11.

. Intestinal malabsorption of HIV-infected children: relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. The Italian Paediatric Intestinal/HIV Study Group. AIDS. 1993; 7(11):1435-40. View

12.

Tejiokem M, Gouandjika I, Beniguel L, Endegue Zanga M, Tene G, Gody J . HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization. PLoS One. 2007; 2(12):e1260. PMC: 2093997. DOI: 10.1371/journal.pone.0001260. View

13.

Wilfert C, Buckley R, Mohanakumar T, Griffith J, Katz S, Whisnant J . Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. 1977; 296(26):1485-9. DOI: 10.1056/NEJM197706302962601. View

14.

Chitsike I, Van Furth R . Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report. BMJ. 1999; 318(7187):841-3. PMC: 27799. DOI: 10.1136/bmj.318.7187.841. View

15.

Kew O, Sutter R, Nottay B, McDONOUGH M, Prevots D, Quick L . Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol. 1998; 36(10):2893-9. PMC: 105084. DOI: 10.1128/JCM.36.10.2893-2899.1998. View

16.

. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001. MMWR Morb Mortal Wkly Rep. 2001; 50(40):874-5. View

17.

Gouandjika-Vasilache I, Akoua-Koffi C, Begaud E, Dosseh A . No evidence of prolonged enterovirus excretion in HIV-seropositive patients. Trop Med Int Health. 2005; 10(8):743-7. DOI: 10.1111/j.1365-3156.2005.01454.x. View

18.

Platt L, Estivariz C, Sutter R . Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis. 2014; 210 Suppl 1:S380-9. PMC: 10424844. DOI: 10.1093/infdis/jiu184. View

19.

Gottlieb G, Sow P, Hawes S, Ndoye I, Redman M, Coll-Seck A . Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis. 2002; 185(7):905-14. DOI: 10.1086/339295. View

20.

Ion-Nedelcu N, Dobrescu A, Strebel P, Sutter R . Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet. 1994; 343(8888):51-2. DOI: 10.1016/s0140-6736(94)90903-2. View